BioRestorative Therapies (BRTX) Receivables - Net (2015 - 2025)
BioRestorative Therapies (BRTX) reported Receivables - Net of $15,500 for Q4 2025, down 91.8% from $188,400 a year earlier but up 15.7% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Receivables - Net (2015 - 2025) Analysis & Trends
Dating back to Q2 2015, BioRestorative Therapies' Receivables - Net record includes 41 quarters.
- Receivables - Net has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- By year, Receivables - Net came in at $188,400 in FY2024 (+876.2%), $19,300 in FY2023 (+20.6%), $16,000 in FY2022 (+220.0%) and $5,000 in FY2021 (-70.6%).
- Five-year quarterly Receivables - Net spans a low of $5,000 in Q4 2021 and a high of $188,400 in Q4 2024.
- Year over year, Receivables - Net has now declined in each of the last four quarters, with growth averaging 133.4% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q4 2024 (growth of 876.2%); the low point was Q3 2025 (a decline of 91.9%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $13,400 (Q3 2025), $15,000 (Q2 2025) and $25,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | BioRestorative Therapies | 687,973.67 | -23.25 Mn | 17,964.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15,500.00 |
| Sep 30, 2025 | 13,400.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 188,400.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 27,400.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 39,300.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 18,000.00 |
API Access
BioRestorative Therapies Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();